links for 2010-02-04

• Doctors increasingly close doors to drug reps, while pharma cuts ranks
  Pharmaceutical companies -- battered by a sluggish drug pipeline, the looming loss of blockbuster patented drugs, an economy in recession and scrutiny of their relationships with physicians -- are re-examining the value of sending drug reps into doctors' offices. Detailers are struggling to grab a shrinking slice of physicians' valuable time and attention.
  (tags: pharmaceutical sales representatives)